Reduction of beta-glucuronidase and nitroreductase activity by yoghurt in a murine colon cancer model.
Yoghurt feeding inhibits induced colon cancer in mice. Several studies showed the immunomodulatory effect of yoghurt which can explain this inhibition. It is possible that yoghurt bacteria can also affect gut flora enzymes related to colon carcinogenesis as reported for other probiotics in different animal tumours. The aim of this work was to evaluate the role of yoghurt starter bacteria and their cell-free fermentation products on the reduction of procarcinogen enzyme activities (beta-glucuronidase and nitroreductase). Mice injected with 1,2-dimethylhydrazine (DMH) and fed with yoghurt were used for this study. Mice given milk or yoghurt supernatant (cell free extract) were used to evaluate if the yoghurt antitumour effect is due to the starter bacteria or other components released during fermentation, that could inhibit these enzymes. We determined that yoghurt by itself maintained enzymes activities similar or lower than non-treatment control group, and the enzyme activity was also lower than milk or yoghurt supernatant groups. DMH increased the activity of the enzymes. Mice injected with DMH and fed cyclically with yoghurt presented lower enzymes activities than the tumour control group. Feeding yoghurt decreased procarcinogenic enzyme levels in the large intestine contents of mice bearing colon tumour. The results of this study provide another mechanism by which yoghurt starter bacteria interact with the large intestine of the mice and prevent colon cancer.
de Moreno de LeBlanc
A
A
Centro de Referencias para Lactobacilos (CERELA). Chacabuco 145, (4000) Tucumin. Argentina.
Perdigón
G
G
D019813:1,2-Dimethylhydrazine; D000818:Animals; D002273:Carcinogens; D002277:Carcinoma / Q000139:chemically induced / Q000201:enzymology / Q000517:prevention & control*; D003106:Colon / Q000378:metabolism / Q000382:microbiology; D003110:Colonic Neoplasms / Q000139:chemically induced / Q000201:enzymology / Q000517:prevention & control*; D004035:Diet Therapy / Q000379:methods*; D004195:Disease Models, Animal; D015536:Down-Regulation / Q000502:physiology; D004789:Enzyme Activation / Q000187:drug effects / Q000502:physiology; D005285:Fermentation / Q000502:physiology; D005966:Glucuronidase / Q000378:metabolism*; D007413:Intestinal Mucosa / Q000378:metabolism / Q000382:microbiology; D007779:Lactobacillus acidophilus / Q000378:metabolism; D051379:Mice; D008807:Mice, Inbred BALB C; D009601:Nitroreductases / Q000378:metabolism*; D016896:Treatment Outcome; D015014:Yogurt / Q000382:microbiology*
D002273:Carcinogens; D009601:Nitroreductases; D005966:Glucuronidase; D019813:1,2-Dimethylhydrazine